|
Status |
Public on Sep 26, 2023 |
Title |
SARS-CoV-2 infection establishes an enhanced, stable, and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using highly restricted TCRs |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
In vitro antigenic challenge identified N222-230 (LLLDRLNQL referred to as LLL) as a dominant epitope that elicited the greatest response (number of responders and magnitude of expansion) from both convalescent and uninfected donors. Analysis of scTCRseq of LLL-specific CD8+ T cells using scTCRseq revealed highly restricted V-gene usage (TRAV12-2) with limited CDR3 motifs, which was supported by structural characterization of a TCR–LLL–HLA-A2 complex. Lastly, transcriptome analysis of CD8+ T cells between expanders and non-expanders identified increased gene expressions associated with differentiation of CD8+ T cells from non- expanders which are shared across the different subsets in a TCR-independent manner. These results show that SARS-CoV-2 infection resulted in significantly enhanced proliferation of LLL-specific CD8+ T cells and suggest that an altered transcriptome is the underlying mechanism controlling activation-induced expansion of LLL-specific CD8+ T cells.
|
|
|
Overall design |
Single Cell sequencing of TCRs and Gene Expression
|
|
|
Contributor(s) |
Weng N, Lu J, Choy C, Chen J |
Citation(s) |
37872153 |
|
Submission date |
Mar 22, 2023 |
Last update date |
Dec 26, 2023 |
Contact name |
Joseph Ruixin Chen |
E-mail(s) |
josephchenmn@gmail.com
|
Phone |
6123568857
|
Organization name |
National Institute of Health
|
Department |
National Institute of Aging
|
Lab |
LMBI
|
Street address |
R323 Pegram 1340 Campus Drive
|
City |
Durham |
State/province |
North Carolina |
ZIP/Postal code |
27708 |
Country |
USA |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (1) |
|
Relations |
BioProject |
PRJNA947597 |